LEADER 02785nam  2200637Ia 450 
001 9910140804903321
005 20170816124407.0
010   $a1-119-95630-7
010   $a1-282-77321-6
010   $a9786612773211
010   $a0-470-71044-6
010   $a0-470-71043-8
035   $a(CKB)2670000000044625
035   $a(EBL)589223
035   $a(OCoLC)667292754
035   $a(SSID)ssj0000410967
035   $a(PQKBManifestationID)11255553
035   $a(PQKBTitleCode)TC0000410967
035   $a(PQKBWorkID)10353105
035   $a(PQKB)10955434
035   $a(MiAaPQ)EBC589223
035   $a(EXLCZ)992670000000044625
100   $a20100317d2010      uy             0
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt
182   $cc
183   $acr
200 00$aAddictive disorders in medical populations$b[electronic resource] /$feditors, Norman S. Miller, Mark S. Gold
210   $aChichester, West Sussex, UK $cWiley-Blackwell$d2010
215   $a1 online resource (647 p.)
300   $aDescription based upon print version of record.
311   $a0-470-74033-7 
320   $aIncludes bibliographical references and index.
327   $aAddictive Disorders in Medical Populations; Contents; List of Contributors; Preface; Acknowledgements; Part One: Addictive disorders and medicine; Part Two: Assessment and diagnosis; Part Three: Addictive disorders and clinical diseases; Part Four: Management of addictive disorders in selected populations; Part Five: Treatment of addictive disorders; Index
330   $aThis book has a much wider focus than traditional books written about drug and alcohol addictions. This unique book is written by medical specialists who diagnose, treat and research addictive disorders in their specialities. Thus, it meets the needs of the typical medical practitioner who wants to learn about and treat patients with addictive disorders in their practices. Because alcohol and drug problems are so prevalent and affect medical conditions profoundly, the medical specialist will improve their knowledge and skill to diagnose and treat addictive disorders in their specialties. Dru
606   $aPatients$xSubstance use
606   $aComorbidity
606   $aDual diagnosis
606   $aSubstance abuse
608   $aElectronic books.
615  0$aPatients$xSubstance use.
615  0$aComorbidity.
615  0$aDual diagnosis.
615  0$aSubstance abuse.
676   $a362.29
676   $a616.86
701   $aMiller$b Norman S$0199239
701   $aGold$b Mark S$0457377
801  0$bMiAaPQ
801  1$bMiAaPQ
801  2$bMiAaPQ
906   $aBOOK
912   $a9910140804903321
996   $aAddictive disorders in medical populations$92210115
997   $aUNINA

LEADER 01603oam  2200421 a 450 
001 9910698510003321
005 20100818111132.0
035   $a(CKB)3460000000106202
035   $a(OCoLC)276361106
035   $a(EXLCZ)993460000000106202
100   $a20081125d2008      ua             0
101 0 $aeng
135   $aurbn|||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aCombating terrorism$b[electronic resource] $elessons learned from London : hearing before the Subcommittee on National Security, Emerging Threats, and International Relations of the Committee on Government Reform, House of Representatives, One Hundred Ninth Congress, second session, September 19, 2006
210  1$aWashington :$cU.S. G.P.O.,$d2008.
215   $aiii, 114 pages $cdigital, PDF file
300   $aTitle from title screen (viewed on Nov. 25, 2008).
300   $aPaper version available for sale by the Supt. of Docs., U.S. G.P.O.
300   $a"Serial no. 109-259."
517   $aCombating terrorism 
606   $aAirlines$xSecurity measures$zUnited States
606   $aTerrorism$xReligious aspects$xIslam
606   $aTerrorism$zUnited States$xPrevention
606   $aTerrorism$zEngland$xPrevention
615  0$aAirlines$xSecurity measures
615  0$aTerrorism$xReligious aspects$xIslam.
615  0$aTerrorism$xPrevention.
615  0$aTerrorism$xPrevention.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aBOOK
912   $a9910698510003321
996   $aCombating terrorism$93120756
997   $aUNINA